{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T11:33:32Z","timestamp":1793705612498,"version":"4.5.1"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Little is known about long-term invasive pneumococcal disease (IPD) incidence in children with risk factors (RFs) in populations with high coverage pneumococcal conjugate vaccine (PCV) programs. We measured IPD burden and changes with PCV use in children by RF status.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A retrospective cohort of all live births in 2001\u20132012 in New South Wales, Australia was linked to IPD, hospitalization and death data. RFs were identified from International Classification of Diseases codes in linked hospitalizations. For each RF adjusted hazard ratios (aHRs, using Cox models), population attributable fractions (PAFs) and changes post-PCV relative to baseline for IPD were calculated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>One-thousand two-hundred fifty-one IPD cases occurred in ~1.1 million children in 12-year study cohort. The 75,404 children (6.8% of cohort) with RFs accounted for 255 (20.4%) IPD cases [rate (per 100,000 person-years) of 61 compared with 14 in no RFs]. Asthma was most common RF (n = 41,074; 3.6%) but highest IPD risk was in 2452 children (0.2%) with immunosuppression, splenic dysfunction or breach in cerebrospinal fluid barrier (aHR~20; PAF 0.7\u20131.8%) versus asthma (aHR 5.3; PAF 14.8%). Compared with 2001\u20132004 birth cohort (baseline), IPD incidence in PCV-eligible 2009\u20132012 birth cohort was 78% (95% confidence interval: \u201372% to \u201382%) less in children without RFs. IPD declined nonsignificantly (13%; 95% confidence interval: \u201370% to +138%) in highest IPD risk group, but by 67% (\u201343% to \u201382%) in children with other RFs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>By 8 years of universal PCV, IPD incidence reduced significantly in all children except in the 0.2% at highest risk, for whom antibiotic prophylaxis and additional vaccine doses are recommended but compliance and effectiveness remain uncertain.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000002407","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T15:37:15Z","timestamp":1565710635000},"page":"967-973","source":"Crossref","is-referenced-by-count":10,"title":["Long-term Vaccine Impact on Invasive Pneumococcal Disease Among Children With Significant Comorbidities in a Large Australian Birth Cohort"],"prefix":"10.1097","volume":"38","author":[{"given":"Sanjay","family":"Jayasinghe","sequence":"first","affiliation":[{"name":"National Centre for Immunisation Research and Surveillance for Vaccine Preventable Diseases, Westmead, New South Wales, Australia"},{"name":"Discipline of Child and Adolescent Health, Children\u2019s Hospital Westmead Clinical School, Faculty of Medicine and Health, University of Sydney"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bette","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Public Health and Community Medicine, University of New South Wales"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Gidding","sequence":"additional","affiliation":[{"name":"National Centre for Immunisation Research and Surveillance for Vaccine Preventable Diseases, Westmead, New South Wales, Australia"},{"name":"School of Public Health and Community Medicine, University of New South Wales"},{"name":"Northern Clinical School, Faculty of Medicine and Health, University of Sydney"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Gibson","sequence":"additional","affiliation":[{"name":"Centre for Big Data Research in Health, University of New South Wales"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clayton","family":"Chiu","sequence":"additional","affiliation":[{"name":"National Centre for Immunisation Research and Surveillance for Vaccine Preventable Diseases, Westmead, New South Wales, Australia"},{"name":"Discipline of Child and Adolescent Health, Children\u2019s Hospital Westmead Clinical School, Faculty of Medicine and Health, University of Sydney"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"McIntyre","sequence":"additional","affiliation":[{"name":"National Centre for Immunisation Research and Surveillance for Vaccine Preventable Diseases, Westmead, New South Wales, Australia"},{"name":"Discipline of Child and Adolescent Health, Children\u2019s Hospital Westmead Clinical School, Faculty of Medicine and Health, University of Sydney"},{"name":"School of Public Health, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230912","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1542\/peds.2007-1510","article-title":"Risks of invasive pneumococcal disease in children with underlying chronic diseases.","volume":"122","author":"Hjuler","year":"2008","journal-title":"Pediatrics"},{"key":"R2-20230912","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1086\/512814","article-title":"Perinatal and crowding-related risk factors for invasive pneumococcal disease in infants and young children: a population-based case-control study.","volume":"44","author":"Hjuler","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R3-20230912","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1055\/s-2005-925523","article-title":"Streptococcus pneumoniae: epidemiology, risk factors, and clinical features.","volume":"26","author":"Ortqvist","year":"2005","journal-title":"Semin Respir Crit Care Med"},{"key":"R4-20230912","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1542\/peds.2009-2150","article-title":"Risk factors for invasive pneumococcal disease in children in the era of conjugate vaccine use.","volume":"126","author":"Pilishvili","year":"2010","journal-title":"Pediatrics"},{"key":"R5-20230912","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jinf.2012.02.017","article-title":"The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England.","volume":"65","author":"van Hoek","year":"2012","journal-title":"J Infect"},{"key":"R6-20230912","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1055\/s-0029-1202938","article-title":"Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention.","volume":"30","author":"Lynch","year":"2009","journal-title":"Semin Respir Crit Care Med"},{"key":"R7-20230912","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00130832-200312000-00006","article-title":"Primary immunodeficiencies associated with pneumococcal disease.","volume":"3","author":"Picard","year":"2003","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R8-20230912","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.285.13.1729","article-title":"Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: opportunities for prevention in the conjugate vaccine era.","volume":"285","author":"Robinson","year":"2001","journal-title":"JAMA"},{"key":"R9-20230912","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/ijcp.12234","article-title":"The burden of invasive pneumococcal disease in children with underlying risk factors in North America and Europe.","volume":"68","author":"Rose","year":"2014","journal-title":"Int J Clin Pract"},{"key":"R11-20230912","first-page":"505","article-title":"Invasive pneumococcal disease in Australia, 2001.","volume":"26","author":"Roche","year":"2002","journal-title":"Commun Dis Intell Q Rep"},{"key":"R12-20230912","doi-asserted-by":"crossref","first-page":"6666","DOI":"10.1016\/j.vaccine.2015.10.089","article-title":"Evaluation of impact of 23 valent pneumococcal polysaccharide vaccine following 7 valent pneumococcal conjugate vaccine in Australian Indigenous children.","volume":"33","author":"Jayasinghe","year":"2015","journal-title":"Vaccine"},{"key":"R13-20230912","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/cid\/ciw720","article-title":"Long-term impact of a \u201c3\u2009+\u20090\u201d schedule for 7- and 13-valent Pneumococcal Conjugate vaccines on invasive pneumococcal disease in Australia, 2002\u20132014.","volume":"64","author":"Jayasinghe","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R14-20230912","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1016\/j.vaccine.2018.03.058","article-title":"Effectiveness of a 3\u2009+\u20090 pneumococcal conjugate vaccine schedule against invasive pneumococcal disease among a birth cohort of 1.4 million children in Australia.","volume":"36","author":"Gidding","year":"2018","journal-title":"Vaccine"},{"key":"R16-20230912","doi-asserted-by":"crossref","first-page":"e1001517","DOI":"10.1371\/journal.pmed.1001517","article-title":"Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites.","volume":"10","author":"Feikin","year":"2013","journal-title":"PLoS Med"},{"key":"R17-20230912","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1473-3099(11)70090-1","article-title":"Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study.","volume":"11","author":"Miller","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"R18-20230912","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","article-title":"Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.","volume":"201","author":"Pilishvili","year":"2010","journal-title":"J Infect Dis"},{"key":"R19-20230912","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S2213-2600(16)00052-7","article-title":"Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control study.","volume":"4","author":"Moore","year":"2016","journal-title":"Lancet Respir Med"},{"key":"R20-20230912","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(06)69637-2","article-title":"Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study.","volume":"368","author":"Whitney","year":"2006","journal-title":"Lancet"},{"key":"R21-20230912","doi-asserted-by":"crossref","first-page":"e2541548","DOI":"10.17061\/phrp2541548","article-title":"Linkage of routinely collected data in practice: the Centre for Health Record Linkage.","volume":"25","author":"Irvine","year":"2015","journal-title":"Public Health Res Pract"},{"key":"R22-20230912","first-page":"60","article-title":"The Centre for Health Record Linkage: a new resource for health services research and evaluation.","volume":"37","author":"Lawrence","year":"2008","journal-title":"Health Inf Manag"},{"key":"R24-20230912","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/uog.4023","article-title":"Population-based study of antenatal detection of congenital heart disease by ultrasound examination.","volume":"29","author":"Chew","year":"2007","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R26-20230912","doi-asserted-by":"crossref","first-page":"243","DOI":"10.5694\/j.1326-5377.2005.tb07028.x","article-title":"The rising incidence of childhood type 1 diabetes in New South Wales, 1990-2002.","volume":"183","author":"Taplin","year":"2005","journal-title":"Med J Aust"},{"key":"R28-20230912","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.jpeds.2013.06.013","article-title":"Current estimate of Down syndrome population prevalence in the United States.","volume":"163","author":"Presson","year":"2013","journal-title":"J Pediatr"},{"key":"R29-20230912","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/cid\/ciu348","article-title":"Risk of pneumococcal disease in children with chronic medical conditions in the era of pneumococcal conjugate vaccine.","volume":"59","author":"Pelton","year":"2014","journal-title":"Clin Infect Dis"},{"key":"R30-20230912","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1542\/peds.2014-2426","article-title":"Vaccination, underlying comorbidities, and risk of invasive pneumococcal disease.","volume":"135","author":"Yildirim","year":"2015","journal-title":"Pediatrics"},{"key":"R31-20230912","doi-asserted-by":"crossref","first-page":"e804","DOI":"10.1542\/peds.2006-2094","article-title":"Perinatal risk factors for hospitalization for pneumococcal disease in childhood: a population-based cohort study.","volume":"119","author":"Mahon","year":"2007","journal-title":"Pediatrics"},{"key":"R32-20230912","article-title":"Invasive pneumococcal disease in UK children <1 year of age in the post\u201313-valent pneumococcal conjugate vaccine era: what are the risks now?","author":"Kent","year":"2018","journal-title":"Clin Infect Dis"},{"key":"R33-20230912","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/INF.0b013e3181fab1cf","article-title":"Underlying conditions in children with invasive pneumococcal disease in the conjugate vaccine era.","volume":"30","author":"Hsu","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R34-20230912","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1016\/j.vaccine.2016.07.031","article-title":"Unaltered pneumococcal carriage prevalence due to expansion of non-vaccine types of low invasive potential 8years after vaccine introduction in Stockholm, Sweden.","volume":"34","author":"Lindstrand","year":"2016","journal-title":"Vaccine"},{"key":"R35-20230912","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1086\/504802","article-title":"Effect of community-wide conjugate pneumococcal vaccine use in infancy on nasopharyngeal carriage through 3 years of age: a cross-sectional study in a high-risk population.","volume":"43","author":"Millar","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R36-20230912","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1097\/INF.0b013e3182788fdd","article-title":"Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine.","volume":"32","author":"Sharma","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R37-20230912","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1016\/j.vaccine.2016.03.107","article-title":"Status of research and development of pediatric vaccines for Streptococcus pneumoniae.","volume":"34","author":"Alderson","year":"2016","journal-title":"Vaccine"},{"issue":"2, pt 1","key":"R38-20230912","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1542\/peds.106.2.362","article-title":"Committee on Infectious Diseases. Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis.","volume":"106","year":"2000","journal-title":"Pediatrics"},{"key":"R39-20230912","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/imj.13348","article-title":"Spleen Australia guidelines for the prevention of sepsis in patients with asplenia and hyposplenism in Australia and New Zealand.","volume":"47","author":"Kanhutu","year":"2017","journal-title":"Intern Med J"},{"key":"R40-20230912","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1365-2141.2011.08843.x","article-title":"Review of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen: prepared on behalf of the British Committee for standards in haematology by a working party of the Haemato-Oncology task force.","volume":"155","author":"Davies","year":"2011","journal-title":"Br J Haematol"},{"key":"R41-20230912","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1445-2197.2006.03775.x","article-title":"Adherence to guidelines for prevention of postsplenectomy sepsis. Age and sex are risk factors: a five-year retrospective review.","volume":"76","author":"Kotsanas","year":"2006","journal-title":"ANZ J Surg"},{"key":"R42-20230912","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1056\/NEJMcp1314291","article-title":"Clinical practice. Care of the asplenic patient.","volume":"371","author":"Rubin","year":"2014","journal-title":"N Engl J Med"},{"key":"R43-20230912","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1016\/j.vaccine.2015.04.079","article-title":"Long term population impact of seven-valent pneumococcal conjugate vaccine with a \u201c3\u2009+\u20090\u201d schedule-How do \u201c2\u2009+\u20091\u201d and \u201c3\u2009+\u20091\u201d schedules compare?","volume":"33","author":"Lowbridge","year":"2015","journal-title":"Vaccine"},{"issue":"suppl","key":"R44-20230912","first-page":"S22","article-title":"Epidemiology of invasive pneumococcal disease in urban New South Wales, 1997-1999.","volume":"173","author":"McIntyre","year":"2000","journal-title":"Med J Aust"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002407","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T22:55:00Z","timestamp":1694559300000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000002407","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]}}}